Inside Supio & the Platform Mass Torts Shaping 2026


The AI Paradox: Automate Less, Win More

Most law firms are using AI wrong.

This week on the podcast, Jon and Marc sat down with Jerry Zhou, Co-Founder and CEO of Supio, to unpack what separates truly AI-native firms from those still treating it like glorified spell-check.

Here's what you'll learn:

⚡️ Why most firms are stuck at "cruise control" with AI

💡 The ChatGPT security risk that's putting your client data at risk

🎯 How AI helped win a $60M verdict by processing 42,000 pages of medical records

🚫 What AI will never replace (and why that's your competitive advantage)

⏰ Why pre-litigation will be fully autonomous in 36 months

If you're still waiting for AI to prove itself, this episode explains why you're already behind and what to do about it.

video preview

This Week on Tort Talk

Jon and Joe Fantini unpack the newest wave of platform-era mass torts reshaping the landscape heading into 2026.

From gaming and ridesharing to over-the-counter drugs, here’s where momentum sits this week:

🎮 Roblox: The Texas Attorney General has sued the platform for allegedly deceiving parents, as more than 50 cases move toward an MDL following the December JPML hearing.

💊 Tylenol: Texas joins the growing list of states taking aim at Johnson & Johnson and Kenvue for allegedly deceptive marketing to pregnant mothers. Meanwhile, the Second Circuit prepares for a pivotal ruling that could revive thousands of claims.

📱 Social Media Addiction: The first state court trial is locked for January 2026 in Los Angeles, with parallel MDL action expected by spring.

🎰 Online Gambling: A new litigation category is emerging as plaintiffs allege algorithm-driven addiction and deceptive engagement tactics.

🚗 Uber: Nearly 10,000 claims are pending across state and federal courts, with the next MDL trial scheduled for early 2026.

video preview

Subscribe to The Jon & Marc Podcast on YouTube, Apple Podcasts, or Spotify for law firm growth strategies and legal marketing news from Jon, Marc, and the industry's top tier legal & marketing professionals.

Follow us on Instagram and TikTok for daily reels and advice.

Get in touch

Your comments and feedback are welcomed, as we strive to bring you the toolkit needed to grow your firm today, and to plan for the future.

113 Cherry St #92768, Seattle, WA 98104-2205
Unsubscribe · Preferences

Jon & Marc

Jon & Marc are marketing technologists, exploring the future of law and legal marketing, interviewing the legal industry’s leaders and boldest thinkers, sharing their insights at the intersection of legal practice and innovation.

Read more from Jon & Marc

Confessions of a Law Firm CMO: What Really Drives Growth Most firms think they have a marketing strategy. What they really have is paid traffic and guesswork. This week on the podcast, Marc sat down with Trudy Emlaw, former CMO of Mike Morse Law Firm and current CMO at George Sink Injury Lawyers, to break down what law firms with real, predictable growth are doing differently. Tune in and learn: 📊 The data foundation that instantly exposes wasted spend 🏆 How brand equity quietly becomes your...

Two Generations, One Strategy: Sustained Growth at Scale Some firms grow fast. Very few keep growing for 45 years. This week on The Jon & Marc Podcast, we sat with two generations of the Farah family to break down how a multi-office PI powerhouse keeps scaling without losing its culture. In this episode, the Farahs share how they: 🏛️ Turn family succession into a growth strategy instead of an inherited role ⚖️ Protect culture by holding their own kids to the same standards as everyone else 💼...

Your Weekly Tort Talk Briefing Jon, Marc, and Joe Fantini break down several major developments that are shifting the mass tort landscape as we approach 2026. Here are the key updates: 🌱 Roundup: Bayer withdrew appeals on several large plaintiff verdicts, including the $2.1 billion Georgia judgment. Similar moves in Philadelphia suggest a broader strategy to resolve high-exposure cases while waiting on the Supreme Court. 🧼 Talc: The first post-bankruptcy ovarian cancer trial against Johnson &...